{"name": "Tioga Pharmaceuticals",
 "permalink": "tioga-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/tioga-pharmaceuticals",
 "homepage_url": "http://www.tiogapharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "858-677-6077",
 "description": "",
 "created_at": "Fri Feb 19 13:02:13 UTC 2010",
 "updated_at": "Fri Apr 13 02:06:05 UTC 2012",
 "overview": "\u003Cp\u003ETioga Pharmaceuticals, Inc. develops therapies for the treatment of gastrointestinal diseases. Its product includes asimadoline, an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia. The company was founded in 2005 and is based in San Diego, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       58],
      "assets/images/resized/0007/7570/77570v1-max-150x150.png"],
     [[250,
       97],
      "assets/images/resized/0007/7570/77570v1-max-250x250.png"],
     [[252,
       98],
      "assets/images/resized/0007/7570/77570v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Stuart",
      "last_name": "J. M. Collinson",
      "permalink": "stuart-j-m-collinson",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "David",
      "last_name": "Urso",
      "permalink": "david-urso",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$52M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.tiogapharma.com/press/Tioga%20Feb%202010%20Financing%20PR.pdf",
    "source_description": "Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 2,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forward Ventures",
         "permalink": "forward-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9546/49546v1-max-150x150.png"],
             [[250,
               33],
              "assets/images/resized/0004/9546/49546v1-max-250x250.png"],
             [[384,
               52],
              "assets/images/resized/0004/9546/49546v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BB Biotech Ventures",
         "permalink": "bb-biotech-ventures",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/9243/49243v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0004/9243/49243v2-max-250x250.png"],
             [[280,
               41],
              "assets/images/resized/0004/9243/49243v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Genesys Capital",
         "permalink": "genesys-capital",
         "image":
          {"available_sizes":
            [[[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-150x150.jpg"],
             [[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-250x250.jpg"],
             [[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.tiogapharma.com/press/BioWorldToday1092006.pdf",
    "source_description": "Tioga\u0092s Series A Round: $24M For Phase IIb Trial Of IBS Drug",
    "raised_amount": 24000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 1,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forward Ventures",
         "permalink": "forward-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9546/49546v1-max-150x150.png"],
             [[250,
               33],
              "assets/images/resized/0004/9546/49546v1-max-250x250.png"],
             [[384,
               52],
              "assets/images/resized/0004/9546/49546v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BB Biotech Ventures",
         "permalink": "bb-biotech-ventures",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/9243/49243v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0004/9243/49243v2-max-250x250.png"],
             [[280,
               41],
              "assets/images/resized/0004/9243/49243v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.tiogapharma.com/press/Tioga%20Series%20B%20PR%20FINAL.pdf",
    "source_description": "Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Thomas, McNerney \u0026 Partners",
         "permalink": "thomas-mcnerney-partners",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0008/1733/81733v1-max-150x150.png"],
             [[250,
               30],
              "assets/images/resized/0008/1733/81733v1-max-250x250.png"],
             [[450,
               54],
              "assets/images/resized/0008/1733/81733v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Genesys Capital",
         "permalink": "genesys-capital",
         "image":
          {"available_sizes":
            [[[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-150x150.jpg"],
             [[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-250x250.jpg"],
             [[141,
               41],
              "assets/images/resized/0006/1284/61284v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "9393 Towne Centre Drive",
    "address2": "Suite 200",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}